Intermediate Research Fellowships (4 years)
The principle objective of The Kay Kendall Leukaemia Fund Intermediate Research Fellowship programme is to facilitate the careers of truly outstanding biomedical scientists by allowing them to gain experience in an international centre of excellence or to establish an independent research group of their own. Non-medical applicants will already have completed their PhD and will usually have 3-8 years of post-doctoral research experience. For medical graduates the Intermediate Fellowship is suitable for individuals who have obtained a PhD; in exceptional cases completion of clinical training during an Intermediate Fellowship may also be possible. Applicants for the Intermediate Fellowship will be expected to demonstrate their potential for achieving international status as researchers in leukaemia or a closely related field.
The Intermediate Fellowship will be for up to 4 years. The Fellowship will support the salary of the Fellow; applicants may also include a salary for technical support in their application and this will be considered on an individual basis. A significant proportion of an Intermediate Fellowship (up to 3 years) may be spent in an appropriate institution outside the UK where this can be clearly demonstrated to be of significant benefit. In such cases applications can include a family allowance cost element in their application if appropriate.
Designation of post
The incumbent will be designated Kay Kendall Leukaemia Fund Intermediate Research Fellow.
Personal and academic background of candidates
Only scientists of the highest calibre will be offered a Fellowship. If, in the judgement of the selection panel, no candidate of sufficiently high standard is found, then no appointment will be made.
The candidate is likely to be a non-clinical biomedical scientist or a clinician with a background in basic research and have a recognised higher degree (PhD or equivalent), although exceptions may be made in special circumstances. Applicants may be of any nationality, however they must be based in a university department or equivalent department in the UK with the expectation of remaining in the UK thereafter.
Work to be supported
The work to be supported will typically address one or more questions relating to epidemiology, aetiology, pathogenesis, diagnosis or treatment of leukaemia or a closely allied malignancy.
The application must be accompanied by a statement from the departmental chairman or laboratory director indicating that he/she has read the research application and is prepared to make available all appropriate facilities if the candidate is awarded an Intermediate Fellowship.
The application should include a scientific proposal of up to 6 single-spaced pages plus references. It will be treated as a confidential document but will inevitably be seen by selected external reviewers.
Applicants should complete the approved application form which should be submitted by email only with all relevant signatures, documents, letters of support etc. It must include the research proposal (aims, background, plan of investigation, justification for budget), CV and letter of support. Applications should also include a 2-page CV for each supervisor/mentor to include selected published papers and current grants. Interviews will take place in London in the summer.
Invitation for applications and application deadlines
The availability of KKLF Intermediate Fellowships will be advertised in Nature, The British Journal of Haematology, The BMJ Clinical edition, and on jobs.ac.uk in March and April 2021. The application process is competitive and subject to peer review.
The deadline for applications for Intermediate Fellowships is 1 July 2021 for consideration at the November 2021 meeting. Interviews for shortlisted candidates are likely to be in October/November 2021.
For further information and/or an application form please contact firstname.lastname@example.org